Sunday, Jun 16, 2024
engineered enzymes for better healthcare


Enzolve Technologies has now successfully launched its Phenylketonuria (PKU) screening test (April 2009). This has completed the CE marking approval process and is the first in the NeoScreenPak series to which two additional tests, one for galactosaemia (Total Galactose) and another for glucose-6P dehydrogenase deficiency (G6PD), will be added soon.

Technology Advantages Pipeline

Language Selection